Europe CRO Companies

Parexel Acquired US-based Clinical Trials Services by Catalent Pharma Solutions for €1.2 billion, aiming to strengthen its global footprint and capabilities.

ICON Purchased US-based PRA Healthsciences in a $12 billion deal, solidifying its position as a leading global CRO.

BioPharma Services Holding Received a €475 million investment from the Carlyle Group to support its European expansion and clinical development services.

Syneos Health Announced a strategic partnership with the University of Oxford to establish a center for excellence in clinical research and innovation.IQVIA Launched a new AI-powered platform, IQuintain, to optimize clinical trial design and conduct.

List of Europe CRO Key Companies in the Market

• Pharmaceutical Product Development, LLC (Thermo Fisher Scientific ) (U.S.)


• Medpace Holdings, Inc. (U.S.)


• Parexel International Corporation (Ireland)


• IQVIA (U.S.)


• Laboratory Corporation of America Holdings (U.S.)


• Charles River Laboratories (U.S.)


• PHASTAR (U.K.)


• Oy 4Pharma Ltd (Finland)


• PSI (Switzerland)


• Icon plc (Ireland)